Compounds > plerixafor
Page last updated: 2024-08-24

plerixafor and Melanoma

plerixafor has been researched along with Melanoma in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bi, J; Fan, X; Ge, S; He, J; Jia, R; Li, C; Li, P; Wang, Y; Zhang, H1
Hwang, ST; Takekoshi, T; Volkman, BF; Ziarek, JJ1
Ascierto, PA; Botti, G; Calemma, R; Caracò, C; Castello, G; Castiglia, D; De Michele, I; Franco, R; Giuliano, P; Ieranò, C; Lombardi, ML; Luongo, M; Mauro, F; Napolitano, M; Nicoletti, G; Ottaiano, A; Satriano, RA; Scala, S; Simeone, E1

Other Studies

3 other study(ies) available for plerixafor and Melanoma

ArticleYear
The SDF-1/CXCR4 chemokine axis in uveal melanoma cell proliferation and migration.
    Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2016, Volume: 37, Issue:3

    Topics: Benzylamines; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chemokine CXCL12; Cyclams; Gene Expression; Heterocyclic Compounds; Humans; Melanoma; Receptors, CXCR4; Uveal Neoplasms

2016
A locked, dimeric CXCL12 variant effectively inhibits pulmonary metastasis of CXCR4-expressing melanoma cells due to enhanced serum stability.
    Molecular cancer therapeutics, 2012, Volume: 11, Issue:11

    Topics: Animals; Benzylamines; Calcium; Cell Proliferation; Chemokine CXCL12; Cyclams; Dipeptidyl Peptidase 4; Heterocyclic Compounds; Humans; Lung Neoplasms; Matrix Metalloproteinase 2; Melanoma; Mice; Mice, Inbred C57BL; Protein Multimerization; Protein Stability; Receptors, CXCR4; Serum

2012
Human melanoma metastases express functional CXCR4.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2006, Apr-15, Volume: 12, Issue:8

    Topics: Benzylamines; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Chemokine CXCL12; Chemokines, CXC; Cyclams; Enzyme Activation; Fluorescent Antibody Technique; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds; Humans; Immunohistochemistry; Melanoma; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Receptors, Chemokine; Receptors, CXCR4; Reverse Transcriptase Polymerase Chain Reaction; Skin; Time Factors

2006